Stephen Goodall
Research Subjects
Research Interests
Stephen Goodall has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Dion Auriac
Vapotronics Limited, Clunies Ross Centre, Eight Mile Plains, Queensland Australia
1 shared publicationKim Chan
Faculty of Pharmacy, University of Sydney, Sydney, Australia
1 shared publicationMichael J. Waters
Department of Physiology and Pharmacology, University of Queensland, St. Lucia, Queensland Australia
1 shared publicationNora Chew
Faculty of Pharmacy, University of Sydney, Sydney, Australia
1 shared publication
Latest Publications
- 1 September 2002
- Published by SAGE Publications in Journal of Aerosol Medicine
- Vol. 15 (3) , 351-357
Aerosolization of Protein Solutions Using Thermal Inkjet Technology
Vapotronics Inc. is developing the thermal inkjet (TIJ) technology used extensively in the printer industry to create a digital aerosol inhaler for the inhalation of therapeutics for local and systemic delivery. The operation of thermal inkjet printers requires generation of high temperatures and vaporization of the liquid formulation to effect droplet ejection. A study was conducted to develop formulations that would permit the generation of aerosols of therapeutic proteins without damage to the inkjet system or degradation of the proteins. Two proteins, human growth hormone and insulin, were formulated and aerosolized. The aerosol was collected and subjected to assays to compare the physicochemical and biological activities of these proteins before and after aerosolization. In each case, there was no significant changes to the proteins as a result of the aerosolization, providing evidence that TIJ can be used for aerosolizing solutions of protein therapeutics.
- 1 September 2002
- Published by SAGE Publications in Journal of Aerosol Medicine
- Vol. 15 (3) , 351-357
Aerosolization of Protein Solutions Using Thermal Inkjet Technology
Vapotronics Inc. is developing the thermal inkjet (TIJ) technology used extensively in the printer industry to create a digital aerosol inhaler for the inhalation of therapeutics for local and systemic delivery. The operation of thermal inkjet printers requires generation of high temperatures and vaporization of the liquid formulation to effect droplet ejection. A study was conducted to develop formulations that would permit the generation of aerosols of therapeutic proteins without damage to the inkjet system or degradation of the proteins. Two proteins, human growth hormone and insulin, were formulated and aerosolized. The aerosol was collected and subjected to assays to compare the physicochemical and biological activities of these proteins before and after aerosolization. In each case, there was no significant changes to the proteins as a result of the aerosolization, providing evidence that TIJ can be used for aerosolizing solutions of protein therapeutics.